PUBLIC COMPANY
saveJanssen Biotech Inc
updated 1mo ago
Johnson & Johnson Innovative Medicine is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
community read0 votes
pipeline
22
marketed
8
phase 3
0
catalysts ytd
8
approvals ytd
8
recalls ytd
0
Pipeline(22)
view full pipeline →pipeline depth22 products
1Phase 11Phase 28Marketed12Unknown
Marketed
(daratumumab + hyaluronidase (human recombinant))
Multiple Myeloma (Kahler Disease)
Marketed(macitentan + tadalafil)
Pulmonary Arterial Hypertension
MarketedSimponi Aria
Rheumatoid Arthritis
Marketedamivantamab
Non-Small Cell Lung Cancer
Marketedciltacabtagene autoleucel
Refractory Multiple Myeloma
MarketedUpcoming
no upcoming catalysts on record
Recent(90d)
approval (1)
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that